| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Departments of Experimental Therapeutics [J-J. B., X-F. L., J. Y., L. W., Y. Y. and R. C. B.], Blood and Marrow Transplantation [R-Y. W., M. A.], Thoracic and Cardiac Surgery [B. F.], Biomathematics [E. N. A.], and Molecular Therapeutics [R. L.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
ARHI, an imprinted putative tumor suppressor gene, encodes a Mr 26,000 GTP-binding protein that is 60% homologous to ras and rap but has a dramatically different function. ARHI expression is down-regulated in a majority of breast and ovarian cancers. Using a dual adenovirus system, we have reexpressed ARHI in ovarian cancer and breast cancer cells that have lost ARHI expression. Reexpression of ARHI inhibited growth, decreased invasiveness, and induced apoptosis. At 5 days after infection with ARHI adenovirus, 3045% of MDA-MB-231 breast cancer cells and 511% of SKOv3 ovarian cancer cells were apoptotic as judged by a terminal deoxynucleotidyl transferase-mediated nick end labeling assay and by Annexin V staining with flow cytometric analysis. Although poly(ADP-ribose) polymerase could be detected immunohistochemically in the nuclei of apoptotic cells, no activation of the effector caspases (caspase 3, 6, 7, or 12) or the initiator caspases (caspase 8 or 9) could be detected in cell lysates using Western blotting. When gene expression was analyzed on a custom cDNA array that contained 2304 known genes, infection with ARHI adenovirus up-regulated 15 genes relative to control cells infected with LacZ adenovirus. The greatest degree of mRNA up-regulation was observed in a Homo sapiens calpain-like protease. On Western blot analysis, calpain protein was increased 23-fold at 35 days after infection with ARHI adenovirus. No increase in calpain protein was observed after LacZ adenovirus infection. Calpain cleavage could be detected after ARHI reexpression, and inhibitors of calpain, but not inhibitors of caspase, partially prevented ARHI-induced apoptosis. Consequently, reexpression of ARHI in breast and ovarian cancer cells appears to induce apoptosis through a caspase-independent, calpain-dependent mechanism.
This article has been cited by other articles:
![]() |
I. Penna, H. Du, R. Ferriani, and H. S. Taylor Calpain5 expression is decreased in endometriosis and regulated by HOXA10 in human endometrial cells Mol. Hum. Reprod., October 1, 2008; 14(10): 613 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lu, R. Z. Luo, H. Peng, D. G. Rosen, E. N. Atkinson, C. Warneke, M. Huang, A. Nishmoto, J. Liu, W. S-L. Liao, et al. Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene ARHI (DRAS3) in Ovarian Cancer Clin. Cancer Res., April 15, 2006; 12(8): 2404 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishimoto, Y. Yu, Z. Lu, X. Mao, Z. Ren, S. S. Watowich, G. B. Mills, W. S-L. Liao, X. Chen, R. C. Bast Jr., et al. A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer Cells Cancer Res., August 1, 2005; 65(15): 6701 - 6710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Elam, L. Hesson, M. D. Vos, K. Eckfeld, C. A. Ellis, A. Bell, D. Krex, M. J. Birrer, F. Latif, and G. J. Clark RRP22 Is a Farnesylated, Nucleolar, Ras-Related Protein with Tumor Suppressor Potential Cancer Res., April 15, 2005; 65(8): 3117 - 3125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujii, R. Z. Luo, J. Yuan, M. Kadota, M. Oshimura, S. R. Dent, Y. Kondo, J.-P. J. Issa, R. C. Bast Jr, and Y. Yu Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation Hum. Mol. Genet., August 1, 2003; 12(15): 1791 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yuan, R. Z. Luo, S. Fujii, L. Wang, W. Hu, M. Andreeff, Y. Pan, M. Kadota, M. Oshimura, A. A. Sahin, et al. Aberrant Methylation and Silencing of ARHI, an Imprinted Tumor Suppressor Gene in which the Function Is Lost in Breast Cancers Cancer Res., July 15, 2003; 63(14): 4174 - 4180. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |